2025 High Throughput Screening (HTS) Industry Trends Report: Long-Term Outlook Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

How Large Will the High Throughput Screening (HTS) Market Size By 2025?
There has been a quick expansion in the size of the high throughput screening (HTS) market over the last few years. The market's value is expected to rise from $22.98 billion in 2024 to $25.49 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.9%. The impressive growth recorded in the previous period is a result of the growing acceptance of high-throughput screening, a surge in r&d investments, greater access to research funds, a rise in healthcare expenditure and a highly competitive market environment.

How Big Is the High Throughput Screening (HTS) Market Size Expected to Grow by 2029?
The market size for high throughput screening (HTS) is anticipated to experience robust expansion in the upcoming years, with predictions estimating it to reach $36 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 9.0%. This upward trend during the forecast period can be ascribed to factors such as increased market size and growth rate, strategic initiatives by key players, a surge in demand for disease monitoring and drug discovery, an escalating incidence of chronic diseases, and a rise in emphasis on the usage of ultra high throughput screening (UHTS) techniques. Notable advancements in high-throughput screening technology and an added focus on the application of ultra high throughput screening (UHTS) techniques constitute major trends in the forecasted period.

View the full report here:
https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report

Which Key Market Drivers Powering High Throughput Screening (HTS) Market Expansion and Growth?
The escalation in chronic disease occurrence is predicted to stimulate the expansion of the high-throughput screening (HTS) market in the future. Chronic disease is a health ailment that lasts over an extended duration, typically beyond three months. HTS allows for the swift testing of numerous chemical substances to identify potential drug candidates that target specific pathways or mechanisms involved in chronic diseases, which is crucial for their effective long-term management. For example, the National Library of Medicine, a US-based government agency, stated in January 2023 that the number of individuals in the US aged 50 and above with a minimum of 1 chronic condition is anticipated to rise to 142.66 million by 2050. Consequently, the increase in chronic disease prevalence is expected to fuel the expansion of the high-throughput screening (HTS) market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14116&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the High Throughput Screening (HTS) Market?
Major firms in the high-throughput screening market are creating innovative items, like multimode plate readers, to offer their customers enhanced features. A multimode plate reader (MPR) is a sophisticated lab instrument used in high-throughput screening, performing analysis on chemical and biological samples in microplates by combining various detection modes all on one platform. Take for example in February 2023, the US-based MedTech company, PerkinElmer Inc., unveiled the EnVision Nexus system. This system distinguishes itself as the quickest and most sensitive multimode plate reader currently available, specifically tailored for the challenging requirements of high-throughput screening (HTS) applications to accelerate drug discovery projects. The platform's stand-out technology comprises dual detectors and optimized reagents like proprietary HTRF and AlphaLISA, together with the latest reagent kits, offering researchers unmatched assay flexibility, precision, speed, and sensitivity. With features for seamless operation such as a plate stacker for 20 or 50 plates or complete automation and integration for continuous around-the-clock, workflow-driven tasks, the EnVision Nexus system endows researchers with the ability to screen millions of samples with an efficiency that is unsurpassed.

What Are the Emerging Segments in the High Throughput Screening (HTS) Market?
The high throughput screening (HTS) market covered in this report is segmented -

1) By Products And Services: Consumables And Reagents, Instruments, Software And Services
2) By Technology: Ultra-High-Throughput Screening, Cell-Based Assays, Lab-On-A-Chip, Label-Free Technology
3) By Application: Target Identification And Validation, Primary And Secondary Screening, Toxicology Assessment, Other Applications
4) By End User: Pharmaceuticals And Biotechnology Industry, Academics And Research Institute, Contract Research Organization, Other End Users

Subsegments:
1) By Consumables And Reagents: Assay Plates, Reagents And Assay Kits, Sample Preparation Kits, Detection Reagents
2) By Instruments: Automated Liquid Handlers, Plate Readers, Robotics And Automation Systems, Microfluidic Devices
3) By Software And Services: Data Analysis Software, HTS Management Software, Consulting Services, Maintenance And Support Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=14116&type=smp

Who Are the Global Leaders in the High Throughput Screening (HTS) Market?
Major companies operating in the high throughput screening (HTS) market are Thermo Fisher Scientific Inc., AstraZeneca Plc, Danaher Corporation, Merck Group, GE HealthCare Technologies Inc., Corning Inc., Agilent Technologies Inc., Lonza Group Ltd., Charles River Laboratories International Inc, Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories, Tecan Group Ltd., Sygnature Discovery Ltd., Luminex Corporation, Hamilton Company, Crown Bioscience Inc., HighRes Biosolutions, NanoTemper Technologies GmbH, BMG LABTECH GmbH, Axxam SpA, Reprocell Inc., BioTek Instruments Inc, Aurora Biomed Inc., Cyclica Inc., Biomat Srl, Diana Biotechnologies s.r.o

Which are the Top Profitable Regional Markets for the High Throughput Screening (HTS) Industry?
North America was the largest region in the high throughput screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high throughput screening (HTS) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14116

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.